Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.

Anderson S, Douglas MC, Valentine R, Grocutt L, Inman GJ, Hay L, Wright S, Mair K, Kelly C, Seddon R, Shaw A, A M, Gourlay J, Flach J, Au E, Vens C, Schoenherr C, Grose D, Lamb C, Schipani S, Vohra S, Wilson C, Paterson C

Open source

DOI: 10.1016/j.ctro.2026.101245
Published: 2026 Sep
Container: Clinical and translational radiation oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctro.2026.101245,
  title = {Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.},
  author = {Anderson S and Douglas MC and Valentine R and Grocutt L and Inman GJ and Hay L and Wright S and Mair K and Kelly C and Seddon R and Shaw A and A M and Gourlay J and Flach J and Au E and Vens C and Schoenherr C and Grose D and Lamb C and Schipani S and Vohra S and Wilson C and Paterson C},
  year = {2026},
  journal = {Clinical and translational radiation oncology},
  doi = {10.1016/j.ctro.2026.101245},
  url = {https://doi.org/10.1016/j.ctro.2026.101245}
}

RIS

TY  - JOUR
TI  - Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.
AU  - Anderson S
AU  - Douglas MC
AU  - Valentine R
AU  - Grocutt L
AU  - Inman GJ
AU  - Hay L
AU  - Wright S
AU  - Mair K
AU  - Kelly C
AU  - Seddon R
AU  - Shaw A
AU  - A M
AU  - Gourlay J
AU  - Flach J
AU  - Au E
AU  - Vens C
AU  - Schoenherr C
AU  - Grose D
AU  - Lamb C
AU  - Schipani S
AU  - Vohra S
AU  - Wilson C
AU  - Paterson C
PY  - 2026
JO  - Clinical and translational radiation oncology
DO  - 10.1016/j.ctro.2026.101245
UR  - https://doi.org/10.1016/j.ctro.2026.101245
ER  -

APA

S, A., MC, D., R, V., L, G., GJ, I., L, H., S, W., K, M., C, K., R, S., A, S., M, A., J, G., J, F., E, A., C, V., C, S., D, G., C, L., S, S., S, V., C, W., & C, P. (2026). Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.. Clinical and translational radiation oncology. https://doi.org/10.1016/j.ctro.2026.101245

Source records

pubmed · retrieved 2026-09-25T15:12:21.771Z